Pharmacokinetics of highly lipophilic antitumor agent palmitoyl rhizoxin incorporated in lipid emulsions in rats

Biological and Pharmaceutical Bulletin

Volumn 19, Issue 2, 1996, Pages 252-258

  Kurihara, Atsushi ^a   Shibayama, Yoko ^a   Mizota, Atsuko ^a   Yasuno, Akiko ^a   Ikeda, Masaru ^a   Hisaoka, Masafumi ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

drug formulation; emulsion; lipophilicity; palmitoyl rhizoxin; pharmacokinetics; rhizoxin

Indexed keywords

ANTINEOPLASTIC AGENT; DIOCTANOYLDECANOYLGLYCEROL; LIPID EMULSION; MACROGOL; N,N DIMETHYLACETAMIDE; PALMITOYLRHIZOXIN; POLYOXYETHYLENE HYDROGENATED CASTOR OIL; RHIZOXIN; RS 1541; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG ISOLATION; INTRAVENOUS DRUG ADMINISTRATION; LIPOPHILICITY; MALE; NONHUMAN; PARTICLE SIZE; RAT; TISSUE DISTRIBUTION;

EID: 0029993739     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.19.252     Document Type: Article

References (20)

1. Noda T., Hashiba T., Sato Z., Ann Phytopathol. Soc. Jpn., 46, 40-45 (1980).
2. Takahashi M., Iwasaki S., Kobayashi H., Okuda S., Murai T., Sato Y., Biochim. Biophys Acta, 926, 215-223 (1987).
3. Lelieveld P., Hendriks H. R., Cancer Treat. Rev., 17, 119-125 (1990).
4. Kobayashi T., Sasagawa K., Hirai K., Nishimura T., Tsuruo T., Iwasaki S., Tsukagoshi S., Okuda S., Abstracts of Papers, The 16th International Congress of Chemotherapy, Jerusalem, Israel, 1989, p. 739.
5. Sasaki H., Kakutani T., Hashida M., Sezaki H., J. Pharm. Sci., 75, 1166-1170 (1986).
6. Couvreur P., Roblot T. L., Poupon M. F., Brasseur F., Puisieux F., Adv. Drug Del. Rev., 5, 209-230 (1990).
7. Collins G. L. C., Lyons R. T., Bartholow L. C., Adv. Drug Del. Rev., 5, 189-208 (1990).
8. Tanaka T., Kaneo Y., Shiramoto S., Iguchi S., Biol. Pharm. Bull., 16, 1270-1275 (1993).
9. Tokui T., Takatori T., Shinozaki N., Ishigami M., Shiraishi A., Ikeda T , Tsuruo T., Cancer Chemother Pharmacol., 36, 1-6 (1995).
10. Yamaguchi T., Tanabe N., Fukushima Y., Nasu T., Hayashi H., Chem. Pharm. Bull , 42, 646-650 (1994).
11. Sakaeda T., Takahashi K., Nishihara Y., Hirano K., Biol. Pharm Bull., 17, 1490-1495 (1994).
12. Takino T., Nakajima C., Takakura Y., Sezaki H., Hashida M , J. Drug Targeting, 1, 117-124 (1993).
13. Kurihara A., Mizota A., Ikeda M., Hisaoka M., Abstracts of Papers, World Congress of Pharmacy and Pharmaceutical Sciences 1993, Tokyo, Japan, September 1993, p. 56.
14. Iwasaki S , Kobayashi H., Furukawa J., Namikoshi M., Okuda S., Sata Z., Matsuda I., Noda T., J. Antibiot., 37, 354-362 (1984).
15. Kim D C., Sugiyama Y., Sato H., Fuwa T., Iga T., Hanano M., J Pharm. Sci., 77, 200-207 (1988).
16. LIU K. X., Kato Y., Narukawa M., Kim D. C., Hanano M., Higuchi O., Nakamura T., Sugiyama Y., Am. J. Physiol., 263, G642-G649 (1992).
17. Tokui T., Kuroiwa C , Tokui Y , Sasagawa K., Kawai K., Kobayashi T., Ikeda T., Komai T., Biopharm. Drug Dispos., 15, 93-108 (1994).
18. Spady D. K., "Lipoproteins as Carriers of Pharmacological Agents," ed. by Shaw J. M., Marcel Dekker, New York, 1991, pp. 1-44.
19. Kurihara A., Shibayama Y., Yasuno A., Ikeda M., Hisaoka M., Biopharm. Drug Dispos.. 16. in press (1996).
20. Kurihara A., Shibayama Y., Mizota A., Yasuno A., Ikeda M., Sasagawa K., Kobayashi T., Hisaoka M., Pharm. Res., 13, in press (1996).